203 related articles for article (PubMed ID: 19091819)
1. Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patients.
Matsuura K; Tanaka Y; Hasegawa I; Ohno T; Tokuda H; Kurbanov F; Sugauchi F; Nojiri S; Joh T; Mizokami M
J Clin Microbiol; 2009 Feb; 47(2):385-9. PubMed ID: 19091819
[TBL] [Abstract][Full Text] [Related]
2. Early phase viral kinetics of chronic hepatitis C patients receiving telaprevir-based triple therapy: a comparison of two real-time PCR assays.
Ogawa E; Furusyo N; Murata M; Toyoda K; Eiraku K; Shimizu M; Harada Y; Mitsumoto F; Takayama K; Okada K; Kainuma M; Hayashi J
Antiviral Res; 2013 Aug; 99(2):119-24. PubMed ID: 23684903
[TBL] [Abstract][Full Text] [Related]
3. Estimation of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA during PEG-IFN plus ribavirin therapy by HCV genotypes and IL28B genotype.
Miyagi Y; Nomura H; Yamashita N; Tanimoto H; Ito K; Masaki N; Mizokami M; Shibuya T
J Infect Chemother; 2013 Feb; 19(1):63-9. PubMed ID: 22821355
[TBL] [Abstract][Full Text] [Related]
4. Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis C.
Ikezaki H; Furusyo N; Ihara T; Hayashi T; Ogawa E; Toyoda K; Taniai H; Kainuma M; Murata M; Hayashi J
J Infect Chemother; 2011 Dec; 17(6):737-43. PubMed ID: 21528383
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
Inoue T; Hmwe SS; Shimada N; Kato K; Ide T; Torimura T; Kumada T; Toyoda H; Tsubota A; Takaguchi K; Wakita T; Tanaka Y
PLoS One; 2017; 12(1):e0170667. PubMed ID: 28118381
[TBL] [Abstract][Full Text] [Related]
6. Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment.
Ogawa E; Furusyo N; Toyoda K; Taniai H; Otaguro S; Kainuma M; Murata M; Sawayama Y; Hayashi J
BMC Gastroenterol; 2010 Apr; 10():38. PubMed ID: 20398383
[TBL] [Abstract][Full Text] [Related]
7. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
[TBL] [Abstract][Full Text] [Related]
8. Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.
Kanda T; Imazeki F; Yonemitsu Y; Mikami S; Takada N; Nishino T; Takashi M; Tsubota A; Kato K; Sugiura N; Tawada A; Wu S; Tanaka T; Nakamoto S; Mikata R; Tada M; Chiba T; Kurihara T; Arai M; Fujiwara K; Kanai F; Yokosuka O
J Viral Hepat; 2011 Jul; 18(7):e292-7. PubMed ID: 21129130
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.
Baleriola C; Rawlinson WD; Dore GJ; Chaverot S; Stelzer-Braid S; Yoshihara M; Crawford D; Sievert W; McCaughan G; Weltman M; Cheng W; Rizkalla B; Dubois D; Thommes J; Roberts S
Antivir Ther; 2011; 16(2):173-80. PubMed ID: 21447866
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.
Ogawa E; Furusyo N; Murata M; Shimizu M; Toyoda K; Hotta T; Uchiumi T; Hayashi J
Antivir Ther; 2017; 22(1):61-70. PubMed ID: 27632789
[TBL] [Abstract][Full Text] [Related]
11. Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy.
Sarrazin C; Shiffman ML; Hadziyannis SJ; Lin A; Colucci G; Ishida H; Zeuzem S
J Hepatol; 2010 Jun; 52(6):832-8. PubMed ID: 20385421
[TBL] [Abstract][Full Text] [Related]
12. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
Martinot-Peignoux M; Khiri H; Leclere L; Maylin S; Marcellin P; Halfon P
J Clin Virol; 2009 Nov; 46(3):216-21. PubMed ID: 19748822
[TBL] [Abstract][Full Text] [Related]
13. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
Halfon P; Pénaranda G; Bourlière M; Khiri H; Masseyeff MF; Ouzan D
J Med Virol; 2006 Feb; 78(2):208-15. PubMed ID: 16372298
[TBL] [Abstract][Full Text] [Related]
14. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
Wolff D; Gerritzen A
Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
[TBL] [Abstract][Full Text] [Related]
16. [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay].
Matsuura K; Tanaka Y; Takagi K; Hiramatsu K; Kani S; Gotoh T; Wakimoto Y; Joh T; Mizokami M
Rinsho Byori; 2007 Nov; 55(11):983-8. PubMed ID: 18154028
[TBL] [Abstract][Full Text] [Related]
17. Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
Ikeda H; Okuse C; Watanabe T; Matsumoto N; Matsunaga K; Shigefuku R; Hattori N; Hiraishi T; Fukuda Y; Noguchi Y; Ishii T; Shima J; Nakahara K; Yamamoto H; Yasuda H; Yotsuyanagi H; Koike K; Itoh F; Suzuki M
Turk J Gastroenterol; 2016 Mar; 27(2):165-72. PubMed ID: 27015621
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection.
Halfon P; Bourlière M; Pénaranda G; Khiri H; Ouzan D
J Clin Microbiol; 2006 Jul; 44(7):2507-11. PubMed ID: 16825372
[TBL] [Abstract][Full Text] [Related]
19. Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C.
Roomer R; van Vuuren AJ; Schutten M; Heijens A; Janssen HL; de Knegt RJ
Antivir Ther; 2011; 16(5):771-4. PubMed ID: 21817199
[TBL] [Abstract][Full Text] [Related]
20. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]